Beth Karlan is a distinguished American physician-scientist and gynecologic oncologist renowned for her pioneering research in the genetic basis and treatment of ovarian cancer. She is a prominent figure in women's cancer research, particularly recognized for her work on BRCA gene mutations and their role in hereditary cancer risk.
Biography Dr. Karlan earned her medical degree from Harvard Medical School and completed her residency in Obstetrics and Gynecology at Yale-New Haven Hospital. She further specialized in gynecologic oncology through a fellowship at the University of California, Los Angeles (UCLA).
Career and Research Dr. Karlan has held significant academic and leadership positions throughout her career. She served as the Director of the Division of Gynecologic Oncology at Cedars-Sinai Medical Center in Los Angeles and as the Director of the Women's Cancer Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute. She is also a Professor of Obstetrics and Gynecology.
Her research has profoundly impacted the understanding and management of ovarian cancer. Key areas of her work include:
- Genetic Susceptibility: Extensive research on the identification of BRCA1 and BRCA2 gene mutations as major risk factors for ovarian and breast cancer, leading to improved genetic testing and counseling strategies.
- Early Detection and Prevention: Development and evaluation of novel screening tools and preventative strategies for high-risk individuals.
- Targeted Therapies: Investigation into new therapeutic approaches, including PARP inhibitors, for ovarian cancer, particularly in patients with genetic mutations.
- Translational Research: Bridging laboratory discoveries with clinical applications to improve patient outcomes.
Dr. Karlan has authored hundreds of peer-reviewed articles, book chapters, and reviews, contributing significantly to the scientific literature in gynecologic oncology. She has been awarded numerous grants from organizations such as the National Cancer Institute (NCI) and has served on various national and international committees and advisory boards, including the National Cancer Advisory Board (NCAB).
Selected Awards and Honors Her contributions have been recognized with numerous accolades, reflecting her impact on cancer research and patient care. She is frequently cited as one of the most influential researchers in her field.
External Links Further information about Beth Karlan's work can typically be found on the websites of Cedars-Sinai Medical Center, major cancer research organizations, and academic medical journals.